[Flow cytometric analysis of DNA ploidy using paraffin-embedded germ cell tumors]. 1991

S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
Department of Urology, Yamaguchi University School of Medicine.

The DNA content of paraffin-embedded materials was determined retrospectively using flow cytometry (FCM) in 36 germ cell tumors, and related to histological type, clinical staging and tumor marker. These histograms were classified from the basis of mode and variance into a diploid and an aneuploid pattern. We could evaluate the DNA histograms in 20 of 36 specimens (56%). Aneuploid patterns were found in 11 of 20 evaluated cases, but there was no correlation between ploidy patterns and histological types. Aneuploid patterns were demonstrated in 2 of 6 stage I cases (33%), and 4 of 5 stage II cases (80%) in seminomas. The difference between stage I and II cases was not statistically significant. There was no correlation between clinical staging and DNA content in non-seminomas. Of the seminomas with elevated human chorionic gonadotropin (HCG) titers, 3 of 4 cases showed aneuploid patterns. These findings indicate that the determination of DNA ploidy in seminomas may prove to be of prognostic value.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010232 Paraffin A mixture of solid hydrocarbons obtained from petroleum. It has a wide range of uses including as a stiffening agent in ointments, as a lubricant, and as a topical anti-inflammatory. It is also commonly used as an embedding material in histology. Parafilm
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004407 Dysgerminoma A malignant ovarian neoplasm, thought to be derived from primordial germ cells of the sexually undifferentiated embryonic gonad. It is the counterpart of the classical seminoma of the testis, to which it is both grossly and histologically identical. Dysgerminomas comprise 16% of all germ cell tumors but are rare before the age of 10, although nearly 50% occur before the age of 20. They are generally considered of low-grade malignancy but may spread if the tumor extends through its capsule and involves lymph nodes or blood vessels. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1646) Disgerminoma,Disgerminomas,Dysgerminomas
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
January 1987, Nihon Sanka Fujinka Gakkai zasshi,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
March 1988, European journal of cancer & clinical oncology,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
August 1998, Urologia internationalis,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
February 1990, Gynecologic oncology,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
January 1985, Cytometry,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
September 1992, American journal of clinical pathology,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
April 1992, Analytical and quantitative cytology and histology,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
July 1990, Cancer research,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
May 1986, Human pathology,
S Yoshihiro, and M Yamamoto, and T Shimabukuro, and H Matsuyama, and N Yamamoto, and J Sakatoku
January 1990, Virchows Archiv. A, Pathological anatomy and histopathology,
Copied contents to your clipboard!